Dual-Task Cost in Bilateral Hearing Loss
A legfontosabb adatok
- Ki végzi
- New York University
- Hol
- New York (Egyesült Államok)Mind a 2 helyszín megnézése
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 67 fő vett részt
- Kezdés
- 2022. febr. 1.
- Befejezés
- 2024. nov. 22.
- A vizsgálat típusa
- Megfigyeléses, 3 csoport
- A vizsgált kezelések
- Gait assessment
- Cognitive assessment
- A regiszteradat frissítve
- 2025. január 13.
Ki vehet részt
- Életkor
- 40 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Részt vehetnek
A regiszter feltételei, szó szerint
Mind a 19 feltétel megnézéseKevesebb
Ki vehet részt
- Adults aged 40 and older with a clinical diagnosis of bilateral symmetrical moderate which is defined as a PTA between 41-55dB HL (0.5-4 kHz) in the better ear
- Adults aged 40 and older with a clinical diagnosis of bilateral symmetrical moderately-severe which is defined as a PTA between 56-70dB HL (0.5-4 kHz) in the better ear
- Adults aged 40 and older with a clinical diagnosis of bilateral symmetrical severe which is defined as a PTA between 71-90dB HL (0.5-4 kHz) in the better ear
- Adults aged 40 and older with a clinical diagnosis of bilateral symmetrical profound which is defined as a PTA above 90+dB HL (0.5-4 kHz) in the better ear
- No asymmetry of HL which is defined as a difference in PTA that is greater than 15 dB between ears or a difference greater than/equal to 20 dB at two contiguous frequencies or greater than/equal to 10 dB at three contiguous frequencies between ears
- Adults aged 40 and older with normal hearing which is defined as a PTA below 25dB (0.5-4 kHz) bilaterally
- Subjects above 65 years of age, with symmetric ARHL in the high frequencies (>3K), with unaided PTA < 40 dB (0.5-4KHz) will be included in the control group as well
Ki nem vehet részt
- Take medications that might influence gait or balance (e.g., methylphenidate)
- Visual impairment above 20/63 (NYS Department of Motor Vehicle cutoff for driving) on the Early Treatment Diabetic Retinopathy Study (ETDRS) Acuity Test that cannot be corrected with lenses
- Any neurological condition interfering with balance or walking (e.g. multiple sclerosis, Parkinson's disease, stroke)
- Currently seeking medical care for another orthopaedic condition or vestibular rehabilitation
- A medical diagnosis of peripheral neuropathy
- Lack of protective sensation based on the Semmes-Weinstein 5.07 Monofilament Test
- Active complaint of dizziness
- Conductive HL or air bone gap
- A recent onset of a sudden HL
- Pregnancy
- Acute musculoskeletal pain at time of testing
- Inability to read an informed consent form in English
Helyszínek itt: Egyesült Államok
- New York Eye and Ear Infirmary of Mount SinaiNew York, Egyesült Államok
- New York University Physical Therapy DepartmentNew York, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
The specific aims of the research study are:
A teljes eredeti leírásKevesebb
1. Compare single-task gait parameters between individuals with hearing loss (HL) and age and education matched controls with normal hearing [normal vs moderate-profound hearing loss (N=23 for each group)]. For that we will compare the primary outcome measure, gait speed, between the groups while participants are walking at a comfortable speed for 1 minute. 2. Compare cognitive function between individuals with HL and age and education matched controls. For that we will compare the Neurocognitive Index, derived from a cognitive assessment between groups. 3. Compare the effect of a cognitive task while walking on gait parameters between people with HL and age education matched controls with normal hearing. For that we will compare the primary outcome measure, gait speed, between groups while participants are walking at a comfortable speed and counting backwards [serial subtraction of 3] for 1 minute. 4. Explore whether cognitive performance (i.e., the Neurocognitive Index) is correlated with Dual task cost (DTC), a deterioration of gait speed while walking and performing concurrent cognitive task [serial subtraction of 3]. The formula to calculate this is the following: DTC = 100 X [(DT - single task)/ single task].
A vizsgálat 3 csoportja
- Control participants with normal hearing.
Adults aged 40 and older with normal hearing will be defined as a PTA below 25dB (0.5-4 kHz) bilaterally.
Kezelés: Gait assessment és Cognitive assessment
- Mild Bilateral Symmetrical Hearing Loss
Adults aged 40 and older with a clinical diagnosis of bilateral symmetrical mild HL in the past three month and on will be defined as a PTA between 26-40dB HL (0.5-4 kHz) in the better ear.
Kezelés: Gait assessment és Cognitive assessment
- >Moderate Bilateral Symmetrical Hearing Loss
Adults aged 40 and older with a clinical diagnosis of bilateral symmetrical moderate, moderately-severe, severe, or profound sensorineural HL in the past three month and on. Moderate hearing will be defined as a PTA between 41-55dB HL (0.5-4 kHz) in the better ear, moderately-severe hearing will be defined as a PTA between 56-70dB HL (0.5-4 kHz) in the better ear, severe HL will be defined as a PTA between 71-90dB HL (0.5-4 kHz) in the better ear and profound HL will be defined as a PTA above 90+dB HL (0.5-4 kHz) in the better ear. Asymmetry of HL will be defined as a difference in PTA that is greater than dB between ears or a difference greater than/equal to 20 dB at two contiguous frequencies or greater than/equal to 10 dB at three contiguous frequencies between ears.
Kezelés: Gait assessment és Cognitive assessment
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Dual-Task Cost During Walking in People With Hearing Loss Compared to Normal Hearing
- A regiszteradat frissítve
- 2025. január 13.